Last year, the U.S. Senate Special Committee on Aging launched a bipartisan effort to expose the public health and national security risks America’s overreliance on foreign-made generic drugs poses to families.
However, a recent piece in Real Clear Markets tried to spin our lifesaving efforts as playing political games, claiming there was little evidence or reason for concern.
Read Full Article »
